Direct-to-consumer raw genetic data can be inaccurate, resulting in harm to patients and unnecessary costs to the health care system, new research suggests.
Today, diagnosing rare genetic diseases requires slow, educated guesswork, but a team of Stanford experts is automating the process.
Physician assistant student Sara Lynne Wright's uncle has a genetic disease that has helped her, and her entire family, be more accepting.
Stanford researchers use gene editing and stem cell technologies to determine whether to worry — or not — about mysterious genetic test results.
Genetic diversity in the receptor for a key reproductive hormone may help explain why some populations have higher rates of preterm birth than others.
A new gene-editing technology enables scientists to make thousands of edits at once and track them with specific barcodes.
Older people are more susceptible to infection, cancer, and autoimmunity than younger people. This may be the result of our immune cells' receiving increasingly random marching orders as we age.
A biobank from the U.K. releases hundreds of thousands of anonymized medical records and genetic data to scientists, who used it to track down new links between genetics and disease.
In a proof-of-principle study, Stanford scientists and colleagues used the CRISPR/Cas9 system to modify genes in coral, suggesting that the tool could one day aid conservation efforts.
Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.
The strange skeletal remains of a fetus discovered in Chile have turned up new insights into the genetics of some bone diseases, according to a new study.
A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
Stanford researchers have discovered a genetic "tuning knob" that can enlarge or shrink bacteria across a wide range - and this can be used to fatten up the bacteria to increase their susceptibility to certain antibiotics.
Protein aggregates in young neural stem cells seem to echo those seen in neurodegenerative disease-- but could they actually be helpful? As the cells age, they become less able to process the aggregates and their ability to activate is dampened.
A new Clinical Genomics Program at Stanford will improve the diagnosis of rare genetic diseases, benefiting patients such as Tessa and Colton Nye.
A woman with a rare genetic eye disease called neovascular inflammatory vitreoretinopathy, or NIV, shares her story.